Several specialized organizations worldwide focus on the manufacture of complex pharmaceutical APIs, notably Abacavir Sodium sulfate, Abarelix, and Abiraterone Mesylate. These compounds present significant difficulties in process development due to their chemical complexity. The manufacturers of these APIs often employ specialized technologies and